Investorideas.com - #Cannabisstocks: Beleave (CSE: $BE.C) (OTCQX: $BLEVF) Subsidiary Reaches Agreement to Lease 27 Hectares of Land in #Colombia
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Thursday, July 5, 2018
Investor Ideas #Potcasts; #Cannabis News and Stocks on the Move; TSX: $WEED.TO, TSX: $ACB.TO, TSX: $APH.TO
Investor Ideas #Potcasts; #Cannabis News
and Stocks on the Move; TSX: $WEED.TO,
TSX: $ACB.TO, TSX: $APH.TO
July 5th Potcast sponsored
by Lexaria Bioscience Corp. (CSE: $LXX.C) (OTC: $LXRP) a #Cannabis company with
a new disruptive drug delivery platform: DehydraTECH
Pt. Roberts, WA; Delta, BC –July 5, 2018
(Investorideas.com Newswire) www.Investorideas.com, a global news source
covering leading sectors including marijuana and hemp stocks and its “potcast’
site, www.potcasts.ca release today’s edition of its series, Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this news in full at http://www.investorideas.com/news/2018/cannabis/07056Potcasts-TSX-WEED-ACB-APH.asp
Today’s podcast overview/transcript:
Good afternoon and welcome to another Investorideas.com potcast ;
looking at cannabis news, stocks to watch as well as insights from thought
leaders and experts.
Today’s potcast was sponsored by Kelowna based Lexaria Bioscience Corp trading on the CSE under symbol LXX and on
the OTC as LXRP. Lexaria has developed a new disruptive
drug delivery platform: DehydraTECH The Company’s patented technology changes
the way Active Pharmaceutical Ingredients (“APIs”) enter the body orally:
1) Masks unwanted tastes – eliminates the need for sugar-filled edibles.
2) Reduces time of onset – effects are felt within 15-20 min vs. 60-120
min.
3) Avoids first-pass liver metabolism
4) Increases bio-absorption by 5-10X
The Company’s DehydraTECH™ technology is patent-protected for multiple
APIs: Cannabidiol (CBD), Tetrahydrocannabinol (THC), Non-steroidal
anti-inflammatory drugs (NSAIDs) such as ibuprofen, Nicotine and Fat soluble
vitamins.
Today’s podcast features announcements from Canopy Growth Corporation (TSX:
WEED and the NYSE: CGC) , Aurora Cannabis Inc. (TSX: ACB and OTCQB: ACBFF) and Aphria Inc. (TSX : APH and USOTC: APHQF).
Canopy
Growth Corporation introduced its Latin American affiliate Canopy LATAM
Corporation ("Canopy LATAM"), a wholly owned and controlled
subsidiary of Canopy Growth Corporation. Through Canopy LATAM, the Company has
acquired Spectrum Cannabis Colombia S.A.S. ("Spectrum Cannabis
Colombia"), which previously operated as Colombian Cannabis S.A.S.
("Colombian Cannabis"), expanding the Company's focus on the emerging
medical cannabis market of Latin America.
This
announcement represents a leap forward in the Company's growth strategy for its
industry leading Spectrum Cannabis brand. As a member of the Canopy Growth
family, Canopy LATAM will focus on advancing medical cannabis and capturing
market share across the region, home to more than 600 million people, as
individual nations modernize their medical cannabis legislation.
Canopy
Growth Corporation also announced that it has closed its previously announced
transaction to acquire the remaining 33% stake of BC Tweed Joint Venture Inc.
("BC Tweed"). The consolidation of the two largest federally
licensed cannabis facilities in the world into full Canopy Growth ownership
cements the Company's commitment to shareholder value through scale production.
"Our BC
Tweed operations have allowed us to pursue and finalize large recreational
supply contracts across Canada," said Mark Zekulin, President and Co-CEO,
Canopy Growth. "Construction and retrofitting work continues at both
greenhouse sites to continue on an aggressive pace towards licensing all 3
million sq. ft. of production."
Finally,
Canopy Growth Corporation also announced the completion of a major supply
agreement with the Alberta Gaming, Liquor & Cannabis Commission
("AGLC") to supply the province with premium cannabis products in a
variety of forms including whole-flower, oil, and Softgel capsules.
Under the
terms of the agreement, the largest of its kind in Canada, Canopy Growth will
supply Alberta with over 15,000 kilograms of cannabis products to support the
first six months of the province's adult use recreational cannabis market set
to open on October 17, 2018. Inventory will be replenished by the Company as
requested and the AGLC reserves the right to extend the agreement for up to two
additional years in 12-month increments. Should the need arise, Canopy Growth
is prepared to go beyond the minimum supply commitment to ensure the AGLC has
sufficient product to meet market demand.
Combining
the Company's supply agreements with six provinces and one territory including
New Brunswick, Newfoundland & Labrador, Prince Edward Island, Quebec,
Yukon, recently announced Manitoba and now Alberta, Canopy Growth is committed
to supply these markets on an annualized basis with up to 61,500 kilograms of
cannabis products in the first year of legal sales with varying incremental
multi-year obligations by province. Supply agreements are supported by a
national production platform which includes a state-of-the-art indoor
production facility located just outside Edmonton, Alberta. Initially announced
in June 2017, the production site ensures that Albertans are accessing Tweed and
other Canopy Growth-affiliated products from a company proudly investing in the
province.
Aurora
Cannabis Inc. announced that it has also entered into an agreement with the
Alberta Gaming, Liquor & Cannabis Commission ("AGLC") to supply
high-quality cannabis products for the adult consumer use market in the
province. Consequently, Aurora will initially allocate up to 25,000 kg of
product for the first 6 months of sales to this market.
Aurora's
three facilities in Alberta - Aurora Sky, Mountain, and Sun - with a combined
funded production capacity of more than 250,000 kg per year, uniquely position
Aurora to provide a reliable, high-quality supply of cannabis to the Province.
Through this agreement, Aurora, which is the leader in the medical cannabis market
in Alberta, will play an important role in ensuring sufficient product is
available to the adult consumer market in the province.
Aphria Inc.
today announced that it has signed a Supply Agreement with the Alberta Gaming,
Liquor & Cannabis Commission as well, to provide a portfolio of
high-quality cannabis and cannabis-derivative products for sale in Alberta's
adult-use market.
Under the
terms of the Agreement, the AGLC has placed an opening order of 870 kg to be
supplied from across the full portfolio of Aphria's adult-use brands and
products, including dried flower, pre-rolls and cannabis oils. Once additional
product categories, such as vapes and edibles, are authorized under the
Cannabis Act, it is anticipated that they will also be made for sale throughout
the province, further enhancing the Company's assortment of offerings in this
market.
Aphria Inc.
also announced that it has successfully completed the divestiture of the
Company's ownership interest in Copperstate Farms, LLC and Copperstate Farms Investors,
LLC previously announced on February 2, 2018. Aphria's original investment
was approximately $11.1 million ($8.2 million USD). Aphria received $20
million as part of the divestiture, realizing a gain of approximately $8.8
million on the sale.
Investor ideas reminds
all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy
products or services or securities. Investors are reminded all investment
involves risk and possible loss of investment.
Lexaria Bioscience Corp. has developed and
out-licenses its disruptive delivery technology that promotes healthier
ingestion methods, lower overall dosing and higher effectiveness of lipophilic
active molecules. Lexaria has multiple patents pending in over 40 countries
around the world and has patents granted in the USA and in Australia for
utilization of its DehydraTECHTM delivery technology. Lexaria's technology
provides increases in intestinal absorption rates; more rapid delivery to the
bloodstream; and important taste-masking benefits, for orally administered
bioactive molecules including cannabinoids, vitamins, non-steroidal
anti-inflammatory drugs (NSAIDs), nicotine and other molecules. www.lexariabioscience.com
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on
iTunes, Google Play Music, Stitcher and Tunein.
Potcasts is now a certified word
mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires
Big Ideas
Investorideas.com is
a meeting place for global investors, featuring news, stock directories, video,
company profiles, interviews and more in leading sectors.
Investorideas.com
cannabis/marijuana and hemp content now includes http://cannabisstocknews.blogspot.com on Blogger.com: the
Investorideas.com news and stock directory pages, a cannabis investor group on Linkedin.com
, the 420 Cannabis Investor ideas www.420cannabisinvestorideas.com, and the new AI site Global Cannabis Investing at www.Globalcannabisinvesting.com
Disclaimer/Disclosure: Investorideas.com is
a digital publisher of third party sourced news, articles and equity research
as well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. Disclosure Lexaria
Bioscience Corp. ( CSE: LXX) (OTC: LXRP) is a media sponsor of the podcast
starting July 5 2018 more info http://www.investorideas.com/About/News/Clientspecifics.asp
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations
of each country.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
Canadian #CannabisStocks and the Passage of Bill C-45; Aphria (TSX: $APH.TO, USOTC: $APHQF), EVITRADE (CSE: $EVA.C), (OTCQB: $AXHLF), Canopy Growth (TSX: $WEED.TO), (NYSE: $CGC), CannTrust (TSX: $TRST.TO)
Canadian #CannabisStocks and the Passage of Bill
C-45; Aphria (TSX: $APH.TO, USOTC: $APHQF), EVITRADE (CSE: $EVA.C), (OTCQB: $AXHLF), Canopy Growth (TSX: $WEED.TO),
(NYSE: $CGC),
CannTrust (TSX:
$TRST.TO)
“Canadians are
expected to spend as much as $7.17 billion on cannabis products in 2019”-
Deloitte
Point Roberts, WA, Delta BC – July 5, 2018 –
Investorideas.com, a global news source and investor resource covering cannabis
stocks issues a sector news alert on Canadian cannabis stocks following the Senate’s
recent passing of Bill C-45 to federally legalize cannabis.
Receiving royal assent, the bill is now officially
law and sales are expected to begin mid-October. Industry analysts are now
releasing new data and trying to predict what this new era of legalized
cannabis will add to the economy.
In a recent Deloitte report, A society in transition, an industry ready to bloom, “Canadians are
expected to spend as much as $7.17 billion on cannabis products in 2019 and
increase their overall consumption by up to 35 per cent once recreational
cannabis is legalized later this year, according to a new report by Deloitte.
Legal recreational cannabis sales could generate up to $4.34 billion in sales,
accounting for more than half of total cannabis sales, but the illegal market
could still be worth more than $1 billion a year.”
“Uruguay and Canada are leading the way on
adult-use legalization, and Germany broke barriers in 2017 on medical-use
availability. This means worldwide spending on legal cannabis should hit $32
billion by 2022,” said Tom Adams, Editor-in-Chief at Arcview Market Research
and Managing Director of BDS Analytics’ Industry Intelligence Division.
As industry and investors gear up for a brave new
world of cannabis in Canada, several companies weighed in on the historic event
and followed up with news demonstrating the momentum the sector is witnessing.
EVITRADE Health Systems Corp. (CSE:EVA) (OTCQB:AXHLF) issued commentary on June 20, 2018 saying,“The Senate overwhelmingly voted in
favour of the revised bill from the House of Commons which should create a
fully federally legal cannabis program for Canada within eight to twelve weeks.
This vote will provide a framework from which companies like ours can utilize
advanced scientific research and developments to operate successfully within
the cannabis market in Canada.”
Two days later EVITRADE Health Systems Corp. issued
follow- up news reporting they had signed a Letter of Intent to collaborate
with West Coast Medical Solutions Ltd. (WCMS). “WCMS together with their
partner Ecovita Packaging Ltd. intend to undertake a project to apply to become
a Licensed Dealer (LD) as issued by Health Canada for Class A precursors. The
Company will focus on uses regarding medical cannabis, THC and cannabidiol
(CBD). Ecovita maintains a relationship with Medtrica Canada which is privately
owned by one of the shareholders of WCMS. Medtrica holds a FDA and Health
Canada MDEL (Medical Device Establishment License) and is an ISO13485 medical
products manufacturer in British Columbia, Canada. Medtrica is also currently
building a brand new 40,000 sq. ft. state of the art manufacturing, processing,
and packaging facility with an estimated completion date in October 2018.”
“This latest agreement provides the manufacturing
capabilities and access to a fully accredited ISO13485 medical device
manufacturing facility; which will greatly strengthen our overall biotech
capabilities and provide a level of integration that will make us more
competitive and efficient." to become a certified Licensed Dealer, we will
be able to further our plans to develop and distribute medical grade products
that can potentially solve a series of ailments that plague the human
condition," said CK Cheung, CEO of Evitrade."
A well-known name on the playing field also issued
a statement following the passage of Bill C-45.
Vic Neufeld, CEO of Aphria (TSX: APH and USOTC: APHQF) said, "Today's passage of Bill C-45 through
the Senate is a historic milestone towards safe and legal recreational cannabis
in Canada. We applaud the government's drive to establish a rational regulatory
framework for adult-use cannabis that is designed to protect public health and
safety, restrict access to youth, and eliminate the black market. It is a
significant day that further cements Canada as the preeminent leader in the
global cannabis sector."
On June 29th Aphria announced that it
has signed a Supply Agreement with the Manitoba Liquor and Lotteries
Corporation to provide a portfolio of high-quality, branded cannabis and
cannabis derivative products for sale in Manitoba's adult-use market.
“Under the terms of the Agreement, the Company will
supply up to 2.7 million grams of cannabis and cannabis derivative products in
the first year of the agreement, including both Ontario and BC dried flower,
pre-rolls and cannabis oils. The wide range of products will be available for
sale at licensed retailers across the province. It is anticipated that
additional products currently being developed by Aphria, such as vapes and
edibles, will also be made available in Manitoba when authorized for sale under
the Cannabis Act.”
Recognized leader and first NYSE listed cannabis
stock, Canopy Growth Corporation (TSX: WEED) (NYSE:CGC) said,”We welcome the recently announced Cannabis
Regulations in support of the Cannabis Act, one of the final steps in the
progression towards a national system for the regulated production, sale and
consumption of quality-controlled cannabis in Canada.”
“The regulations, upon an initial review, present
an exhaustive and sophisticated system for production and marketing, and are
in-line with the Company's expectations. They represent the culmination of
years of experience gained through the medical cannabis system, and will serve
Canadian patients, adult-use consumers, producers and stakeholders well as the
country approaches the end of cannabis prohibition.”
Canopy announced on June 29th they also
had completed an agreement with the Manitoba Liquor and Lotteries Corporation
to supply the province with high quality cannabis products.
“Under the terms of the agreement, Canopy Growth
will supply the Manitoba market with up to 6,500 kilograms of cannabis products
over the next twelve months to meet demand from the adult use recreational cannabis
market set to open on October 17, 2018.”
Commenting on the royal ascent, CannTrust Holdings
Inc. (TSX: TRST) released news saying, “CannTrust is applauding
the granting of Royal Assent to Bill C-45, the Cannabis Act. With Royal Assent
received, the legislation legalizing cannabis for adult consumer use has now
passed its final official step, and retail sales are to commence on October 17,
2018, as announced by Canada's federal government.“
"While the federal government has recently
announced the commencement date for adult consumer use, CannTrust has been
working towards this date for a very long time. We are well positioned for this
rapid growth with our new product offerings, infrastructure, research and
development and staffing. At the same time we continue to lead the medical
industry through our customer support, innovative portfolio and most of all,
our trusted standardized products. Initial adult consumer use order discussions
with the Provinces have exceeded our preliminary estimates reflecting the
market's confidence in our abilities and the understanding of our consistent
quality. This truly is an exciting and momentous time for both our Company and
our nation", says Brad Rogers, President of CannTrust.
CannTrust is initially launching three recreational
brands of Cannabis in Canada – liiv, SYNR.G and Xscape. This trio of brands
will address the needs of three distinct target audiences: the knowledgeable
enthusiast, the social consumer and the experience seeker. Each of the brands
will include a set of carefully curated strains and the products will be
available in a variety of formats including dried flower, pre-rolls, oils and
capsules.
Sources –
Arcview
About
Investorideas.com - News that Inspires Big Ideas
Investorideas.com is a meeting place for global
investors, featuring news, stock directories, video, podcasts, company profiles, interviews and more in leading sectors.
Investorideas.com cannabis/marijuana and hemp news
and investing content includes potcastsCM – podcasts featuring cannabis news and stocks to watch plus
insight from thought leaders and experts. Cannabis content also includes
http://cannabisstocknews.blogspot.com on Blogger.com: the Investorideas.com news and stock directory pages, a
cannabis investor group on Linkedin.com, the 420 Cannabis Investor ideas
directory www.420cannabisinvestorideas.com, and Global
Cannabis Investing at www.Globalcannabisinvesting.com.
Disclaimer/Disclosure:
Investorideas.com is a digital publisher of third party sourced news, articles
and equity research as well as creates original content, including video,
interviews and articles. Original content created by investorideas is protected
by copyright laws other than syndication rights. Our site does not make
recommendations for purchases or sale of stocks, services or products. Nothing
on our sites should be construed as an offer or solicitation to buy or sell
products or securities. All investment involves risk and possible loss of
investment. This site is currently compensated for news publication and
distribution,social media and marketing, content creation and more. Contact
each company directly regarding content and press release questions. Disclosure
is posted for each compensated news release, content published /created if
required but otherwise the news was not compensated for and was published for
the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Additional info regarding BC Residents and global
Investors: Effective September 15 2008 - all BC investors should review all OTC
and Pink sheet listed companies for adherence in new disclosure filings and
filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to
regulations of each country. Disclosure : Investorideas was compensated for
this tag article to include EVITRADE Health Systems Corp.- learn more about
costs and services http://www.investorideas.com/News-Upload/
Contact Investorideas.com
800-665-0411
Tuesday, July 3, 2018
#Cannabisstocks: National Access Cannabis Corp. (TSX VENTURE: META) Provides Update on Manitoba Retail Network
#Cannabisstocks: National Access Cannabis Corp. (TSX VENTURE: META) Provides Update on Manitoba Retail Network
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Get the latest Cannabis and Hemp stock news from www.investorideas.com
#Cannabisstocks: Namaste (TSXV: N) Signs Services Agreement with Indigenous Canadian Medical Dispensaries (IcMD) to Provide Patient Consultations to Over 1.5 Million Indigenous Community Members Exclusively through NamasteMD
#Cannabisstocks: Namaste (TSXV: N) Signs Services Agreement with Indigenous Canadian Medical Dispensaries (IcMD) to Provide Patient Consultations to Over 1.5 Million Indigenous Community Members Exclusively through NamasteMD
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Subscribe to:
Posts (Atom)